Asco annual meeting 2020 dates
ir.medicenna.com
On May 29, 2020, Medicenna announced the virtual presentations of data from its completed Phase 2b trial of MDNA55, an IL4-guided toxin, in patients with rGBM, at the 2020 American Society of Clinical Oncology (“ASCO”) Annual Meeting.
Iovance Biotherapeutics
Results from Cohort 2 of the C-144-01 clinical trial were initially reported at the American Society of Clinical Oncology, or ASCO, annual meeting on June 1, 2019 and will be updated at the ASCO annual meeting on May 29, 2020. In 66 patients with metastatic melanoma, treatment with lifileucel resulted in an ORR of 36.4%, as assessed by ...
ir.medicenna.com
On May 29, 2020, the Corporation also announced the virtual presentation of data on MDNA11, one of its lead candidates from the IL-2 Superkine program, at the 2020 ASCO Annual Meeting. The poster presentation by Dr. Moutih Rafei, PhD (Associate Professor of Pharmacology and Physiology at the University de Montreal), focused on new data arising ...
Investor Relations | AnPac Bio
School of Life Science of Fudan University); 2015 Annual Congress of Chinese Thoracic Society; 2017 ASCO Annual. Meeting, J Clin Oncol 35, e23131, 2017 (co- authors: Shanghai Changhai Hospital and School of Life Science of Fudan. University); 2019 ASCO Annual Meeting, J Clin Oncol 37, e20673, 2019 (co-authors: Shanghai Changhai Hospital and ...
Nearby & related entries:
To fulfill the demand for quickly locating and searching documents.
It is intelligent file search solution for home and business.
Hot searches
- 2020 chemistry marking scheme june paper
- standard deviation worksheet answers pdf
- all commands for windows 10
- dental implants no credit check
- quarterly business review templates free
- seal team six tv show
- minecraft windows 10 edition hacked client download
- statement of research interests sample
- philosophy major careers
- free employee review forms